Patent Assignment
Reel/Frame 058357/0145
Assignment of Assignor's Interest
Recorded: 2021-12-07
Pages: 3
Assignor
CHURCH, SARAH
Executed: 2021-04-19
Assignee
NANOSTRING TECHNOLOGIES, INC.
530 FAIRVIEW AVE. NORTH, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies
Application:
17/290,061 →
Publication:
US 2021/0395374
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 7, 2021
From: DAVIDSON, JAN KENNETH
To: MACROGENICS, INC.
Reel/Frame 058326/0015 →
Assignment of Assignor's Interest
Dec 7, 2021
From: RUTELLA, SERGIO
To: NOTTINGHAM TRENT UNIVERSITY
Reel/Frame 058326/0056 →
Security Interest
Nov 7, 2023
From: NANOSTRING TECHNOLOGIES, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065490/0058 →
Security Interest
Feb 8, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 066528/0634 →
Assignment of Assignor's Interest
May 16, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: BRUKER SPATIAL BIOLOGY, INC.
Reel/Frame 067932/0109 →
Release of Security Interest
May 16, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0565 →
Release of Security Interest
May 16, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: NANOSTRING TECHNOLOGIES, INC.
Reel/Frame 067453/0577 →
Assignment of Assignor's Interest
Oct 17, 2024
From: NANOSTRING TECHNOLOGIES, INC.
To: BRUKER SPATIAL BIOLOGY, INC.
Reel/Frame 069182/0001 →